Short Interest in BIO-key International Inc. (NASDAQ:BKYI) Declines By 27.8%

BIO-key International Inc. (NASDAQ:BKYI) saw a large decrease in short interest in the month of February. As of February 27th, there was short interest totaling 224,434 shares, a decrease of 27.8% from the February 12th total of 310,850 shares. Based on an average trading volume of 275,973 shares, the short-interest ratio is currently 0.8 days. Currently, 2.2% of the shares of the stock are short sold. Currently, 2.2% of the shares of the stock are short sold. Based on an average trading volume of 275,973 shares, the short-interest ratio is currently 0.8 days.

Institutional Trading of BIO-key International

An institutional investor recently raised its position in BIO-key International stock. Geode Capital Management LLC grew its stake in shares of BIO-key International Inc. (NASDAQ:BKYI) by 49.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 48,892 shares of the technology company’s stock after buying an additional 16,271 shares during the quarter. Geode Capital Management LLC owned approximately 0.45% of BIO-key International worth $26,000 as of its most recent SEC filing. 26.51% of the stock is owned by hedge funds and other institutional investors.

BIO-key International Price Performance

Shares of BKYI traded down $0.01 during mid-day trading on Friday, reaching $0.65. The company had a trading volume of 123,447 shares, compared to its average volume of 550,306. The company has a market capitalization of $7.03 million, a price-to-earnings ratio of -0.62 and a beta of 0.41. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.13 and a current ratio of 1.26. The company’s 50 day simple moving average is $0.62 and its 200 day simple moving average is $0.71. BIO-key International has a 1-year low of $0.51 and a 1-year high of $1.97.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Wall Street Zen raised shares of BIO-key International to a “sell” rating in a research note on Saturday, January 3rd. Weiss Ratings restated a “sell (e+)” rating on shares of BIO-key International in a research note on Wednesday, January 21st. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, BIO-key International has an average rating of “Sell”.

About BIO-key International

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.